Intellia Therapeutics (NTLA) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

NTLA is expected to report earnings to fall 7.89% to -139 cents per share on October 31

Intellia Therapeutics NTLA Stock Earnings Reports

Q3'24

Est.

$-1.40

Q2'24

Missed

by $0.30

Q1'24

Beat

by $0.26

Q4'23

Missed

by $0.02

Q3'23

Beat

by $0.12

The last earnings report on August 08 showed earnings per share of -151 cents, missing the estimate of -122 cents. With 1.42M shares outstanding, the current market capitalization sits at 2.13B.

View a ticker or compare two or three

Compare

NTLA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NTLA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NTLA (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

40 Erie Street

Phone

+1 857 285-6200

Employees

526

Web

https://www.intelliatx.com